Table 1. Relationship between LZAP expression and clinicopathological features of 126 patients with hepatocellular carcinoma.
Clinicopathologic variables | number of each group | LZAP expression | p value | |
low | high | |||
All cases | 126 | 76 | 50 | |
Age(years) | 0.216 | |||
<50 | 64 | 42 | 22 | |
≥50 | 62 | 34 | 28 | |
Gender | 0.379 | |||
Male | 115 | 68 | 47 | |
Female | 11 | 8 | 3 | |
Tumor size(cm) | 0.040a | |||
<5 | 54 | 27 | 27 | |
≥5 | 72 | 49 | 23 | |
Histilogical differentiation | 0.001a | |||
Well | 21 | 7 | 14 | |
Moderate | 61 | 34 | 27 | |
Poor | 44 | 35 | 9 | |
Liver cirrhosis | 0.185 | |||
No | 57 | 38 | 19 | |
Yes | 69 | 38 | 31 | |
HBV | 0.722 | |||
Negative | 16 | 9 | 7 | |
Positive | 110 | 67 | 43 | |
Serum AFP | 0.006a | |||
<25 ug/l | 38 | 16 | 22 | |
≥25 ug/l | 88 | 60 | 28 | |
Recurrence | 0.900 | |||
No | 94 | 57 | 37 | |
Yes | 32 | 19 | 13 | |
Distant Metastasis | 0.656 | |||
No | 108 | 66 | 42 | |
Yes | 18 | 10 | 8 |
p value<0.05.